Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
UroGen Pharma Ltd.
13G/A
Amendment 1
URGN · M96088105
|
6.7% |
8/12/2026
Event 6/30/2026
|
|||
| The Toronto-Dominion Bank | 6.7% | ||||
| TD Securities Inc. | 0.2% | ||||
|
Stoke Therapeutics, Inc.
13G/A
Amendment 2
STOK · 86150R107
|
4.9% |
8/12/2026
Event 6/30/2026
|
|||
| The Toronto-Dominion Bank | 4.9% | ||||
| TD Securities Inc. | 0% | ||||
|
eBay Inc.
13G
EBAY · 278642103
|
9.0% |
8/12/2026
Event 6/30/2026
|
|||
| The Toronto-Dominion Bank | 9.0% | ||||
| TD Securities Inc. | 0% | ||||
|
Stoke Therapeutics, Inc.
13G/A
Amendment 1
STOK · 86150R107
|
5.4% |
5/15/2026
Event 3/31/2026
|
|||
| The Toronto-Dominion Bank | 5.4% | ||||
| TD Securities Inc. | 0% | ||||
|
UroGen Pharma Ltd.
13G
URGN · M96088105
|
5.4% |
5/15/2026
Event 3/31/2026
|
|||
| The Toronto-Dominion Bank | 5.4% | ||||
| TD Securities Inc. | 0% | ||||
|
PTC Therapeutics, Inc.
13G/A
Amendment 1
PTCT · 69366J200
|
3.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Immatics N.V.
13G
IMTX · N44445109
|
5.5% |
5/15/2026
Event 3/31/2026
|
|||
|
Greenbrier Companies Inc
13G/A
Amendment 1
GBX · 393657101
|
6.2% |
5/15/2026
Event 3/31/2026
|
|||
| The Toronto-Dominion Bank | 6.2% | ||||
| TD Securities Inc. | 0% | ||||
|
UroGen Pharma Ltd.
13G/A
Amendment 1
URGN · M96088105
|
4.9% |
2/13/2026
Event 12/31/2025
|
|||
|
PTC Therapeutics, Inc.
13G
PTCT · 69366J200
|
5.2% |
2/13/2026
Event 12/31/2025
|
|||
|
Greenbrier Companies Inc
13G
GBX · 393657101
|
6.0% |
2/13/2026
Event 12/31/2025
|
|||
|
UroGen Pharma Ltd.
13G
URGN · M96088105
|
6.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Stoke Therapeutics, Inc.
13G
STOK · 86150R107
|
5.8% |
11/14/2025
Event 9/30/2025
|
|||
|
The Charles Schwab Corporation
13D/A
Amendment 3
SCHW · 808513105
|
0.1% |
2/12/2025
Event 2/10/2025
|
|||
| The Toronto-Dominion Bank | 0.1% | ||||
| TD Group US Holdings LLC | 0% | ||||